Histological Criteria for Encapsulating Peritoneal Sclerosis – A Standardized Approach
Niko Braun(Stuttgart Observatory), Mark Dominik Alscher(Robert Bosch Hospital), Dagmar Biegger(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Juergen Dippon(University of Stuttgart), Stephan Segerer(Kantonsspital Aarau), Christoph Ulmer(Robert Bosch Hospital), Joerg Latus(Robert Bosch Hospital), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Péter Fritz(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Klaus‐Peter Thon(Robert Bosch Hospital), Fabian R. Reimold(Beth Israel Deaconess Medical Center), Martin Kimmel(Robert Bosch Hospital)
Cited by 40
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Oncogenically active MYD88 mutations in human lymphoma
|Nature|2010|1.5k